CATALOGO DEI PRODOTTI DELLA RICERCA

IDOLAZZI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.498
EU - Europa 6.492
AS - Asia 4.342
SA - Sud America 677
AF - Africa 68
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
Totale 19.100
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.393
GB - Regno Unito 2.099
CN - Cina 1.771
SG - Singapore 1.630
RU - Federazione Russa 1.353
DE - Germania 624
BR - Brasile 581
IT - Italia 571
SE - Svezia 477
FR - Francia 413
HK - Hong Kong 403
IE - Irlanda 386
FI - Finlandia 266
VN - Vietnam 95
TR - Turchia 82
UA - Ucraina 82
JP - Giappone 79
IN - India 76
KR - Corea 75
CA - Canada 52
NL - Olanda 50
AR - Argentina 34
MX - Messico 32
PL - Polonia 30
BE - Belgio 29
AT - Austria 26
BD - Bangladesh 25
ZA - Sudafrica 23
ID - Indonesia 22
ES - Italia 20
EC - Ecuador 16
RO - Romania 16
EG - Egitto 13
IR - Iran 13
AU - Australia 10
UZ - Uzbekistan 10
VE - Venezuela 10
CL - Cile 9
CO - Colombia 8
PE - Perù 8
PY - Paraguay 8
SA - Arabia Saudita 7
CH - Svizzera 6
IQ - Iraq 6
MA - Marocco 6
NP - Nepal 6
QA - Qatar 6
GR - Grecia 5
KE - Kenya 5
LT - Lituania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AZ - Azerbaigian 4
DZ - Algeria 4
EU - Europa 4
JM - Giamaica 4
SN - Senegal 4
TG - Togo 4
AL - Albania 3
AM - Armenia 3
BG - Bulgaria 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HR - Croazia 3
IL - Israele 3
KG - Kirghizistan 3
LB - Libano 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
AF - Afghanistan, Repubblica islamica di 2
BO - Bolivia 2
BW - Botswana 2
CU - Cuba 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
IS - Islanda 2
JO - Giordania 2
LV - Lettonia 2
PA - Panama 2
PT - Portogallo 2
TH - Thailandia 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CM - Camerun 1
CY - Cipro 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
ME - Montenegro 1
MK - Macedonia 1
ML - Mali 1
Totale 19.086
Salva come PNG Salva come JPEG
Città #
Southend 1.927
Dallas 1.793
Chandler 942
Singapore 708
Jacksonville 471
Ashburn 460
Hong Kong 398
Woodbridge 390
Dublin 385
Ann Arbor 315
Moscow 315
Beijing 297
Houston 210
Lawrence 160
Princeton 160
Wilmington 155
Jinan 145
Los Angeles 134
New York 131
Bologna 128
Redmond 128
Shenyang 127
Nanjing 122
Verona 102
Helsinki 95
The Dalles 84
Munich 82
Hebei 73
Tokyo 73
Buffalo 71
Tianjin 67
Redondo Beach 57
Zhengzhou 54
Changsha 52
Haikou 51
Ningbo 51
São Paulo 51
Columbus 45
Milan 45
Sindelfingen 43
Taizhou 43
Hangzhou 40
Guangzhou 39
Taiyuan 39
Nanchang 38
Redwood City 34
Santa Clara 33
Jiaxing 31
Ho Chi Minh City 28
London 28
San Francisco 28
Chicago 27
Seattle 26
Turku 26
Brooklyn 25
Brussels 25
Norwalk 25
Lanzhou 24
Rome 24
Denver 23
Fuzhou 23
Warsaw 23
Boardman 22
Hyderabad 22
Washington 22
Düsseldorf 21
Atlanta 19
Dearborn 19
Amsterdam 18
Rio de Janeiro 18
Sanayi 18
Toronto 18
Hanoi 17
Johannesburg 17
Lancaster 17
Brasília 16
Orem 16
Vienna 16
Falls Church 15
Mexico City 15
Nürnberg 15
Orani 15
Phoenix 15
Falkenstein 14
Porto Alegre 14
Belo Horizonte 13
Fairfield 13
Jakarta 13
Montreal 13
Chennai 12
Detroit 12
Manchester 12
Campinas 11
Charlotte 11
Dong Ket 11
Venice 11
Council Bluffs 10
Florianópolis 10
Frankfurt am Main 10
Poplar 10
Totale 12.320
Salva come PNG Salva come JPEG
Nome #
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 312
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 304
Teriparatide and denosumab combination therapy and skeletal metabolism 289
A new instrument for the screening of psoriatic arthritis among psoriatic patients 269
Real-World Effectiveness of Bimekizumab in Predominantly Difficult-to-Treat Patients with Psoriatic Arthritis Followed in a Combined Dermatology-Rheumatology Clinic: A 24-Week Multicenter Study 263
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 204
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 195
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 176
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 173
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 173
Bone metabolism in patients with anorexia nervosa and amenorrhoea 173
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 166
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 165
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 165
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 161
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 158
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 156
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 156
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 154
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 154
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 153
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 152
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 151
Bone involvement and osteoporosis in mastocytosis. 150
Could γ\δ T-cells explain zoledronic acid adverse events? 149
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 149
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 148
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 148
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 148
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 147
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 145
Prevalence and incidence of rheumatoid arthritis in Italy. 144
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 143
DXA bone mineral density in males: retrospective study in real life. 142
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 139
Bone involvement in patient with clonal mast cell disorders 138
Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study 138
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 135
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 135
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 134
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 133
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 133
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 132
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 131
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 130
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 128
Prevalence of osteoporosis in patients affected by mastocytosis 128
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 128
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 127
Vitamin D levels in patients with psoriasis with or without arthritis 126
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 126
Osteopetrosi 124
Focal bone involvement in inflammatory arthritis: the role of IL17 124
Effects of denosumab on peripheral lymphocyte subpopulations 124
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 122
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 122
Development and First Validation of a Disease Activity Score for Gout 122
Sclerostin and DKK1 in primary hyperparathyroidism. 120
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 120
Drug-induced osteonecrosis of the jaw: the state of the art 119
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 118
Periostin: The bone and beyond 118
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 116
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 115
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 115
Duration of treatment for osteoporosis 115
MEDAL con etoricoxib: l’inizio di una nuova era per il trattamento del dolore muscolo scheletrico 113
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 113
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 112
The obesity paradox and osteoporosis 111
Relationship Between Increased Fecal Calprotectin Levels and Interstitial Lung Disease in Systemic Sclerosis 111
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 111
Ruolo della vitamina D 110
Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. 110
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 110
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 109
Effects of secukinumab on serum adipocytokines: preliminary data 109
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 109
Osteoporosi ed attività sportiva: 108
Rheumatoid arthritis, γδ T cells and bisphosphonates 107
Strong relationship between vitamin D status and bone mineral density in anorexia nervosa 107
Previous use of amino-bisphosphonates and circulating gamma/delta T cells 106
Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism 106
Vitamin D and rheumatic diseases. 106
Variazione della densità minerale ossea ed attività antifratturativa; 106
The ultrasonographic spectrum of toe dactylitis in psoriatic arthritis: a descriptive analysis 104
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 104
Rapid skeletal turnover in radiographic mimic of osteopetrosis might be secondary to systemic mastocytosis [corrected] 104
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 104
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 104
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 104
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 104
Vitamin D and fractures: a systematic review 103
Could nail and joint alterations make the difference between psoriatic arthritis and osteoarthritis during the ultrasonographic evaluation of the distal interphalangeal joints? 103
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 103
Surgical Treatment of Symptomatic Aortic Aneurysm in a Patient with Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis: Case Report and Review of the Literature 103
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 103
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 103
Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. 102
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis 102
Totale 13.694
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.317
article - articoli 67.414
book - libri 0
conference - conferenze 540
curatela - curatele 0
other - altro 363
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.634
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021609 0 0 0 0 182 122 20 43 81 11 107 43
2021/20221.206 93 347 7 62 54 29 24 65 81 24 85 335
2022/20232.688 191 289 242 491 213 650 45 145 291 30 76 25
2023/20241.251 54 113 107 152 158 180 60 126 6 37 189 69
2024/20253.160 152 221 152 493 145 111 163 147 472 262 282 560
2025/20265.058 720 506 1.906 1.674 252 0 0 0 0 0 0 0
Totale 19.440